Sulfation in Acetaminophen-Induced Liver Injury: Friend or Foe?

SIRT6 as a key event linking p53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation

(2020) Yanying Zhou et al.   Acta Pharmaceutica Sinica B

Endoplasmic Reticulum Stress-induced Upregulation of STARD1 Promotes Acetaminophen-induced Acute Liver Failure

(2019) Sandra Torres et al.   GASTROENTEROLOGY

An Unexpected Role of Cholesterol Sulfotransferase and its Regulation in Sensitizing Mice to Acetaminophen-Induced Liver Injury

(2019) Yunqi An et al.   MOLECULAR PHARMACOLOGY

Fibrogenic Activity of MECP2 is Regulated by Phosphorylation in Hepatic Stellate Cells

(2019) Eva Moran-Salvador et al.   GASTROENTEROLOGY

Acetaminophen-induced Acute Liver Failure Is More Common and More Severe in Women

(2018) Jessica B. Rubin et al.   Clinical Gastroenterology and Hepatology

Acetaminophen (APAP or N-Acetyl-p-Aminophenol) and Acute Liver Failure

(2018) Chalermrat Bunchorntavakul et al.   Clinics in Liver Disease

Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers

(2017) Michael H. Court et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury

(2016) Francisco Javier Cubero et al.   GASTROENTEROLOGY

Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer

(2016) Ada W.Y. Leung et al.   Oncotarget

Metabolism and Disposition of Acetaminophen: Recent Advances in Relation to Hepatotoxicity and Diagnosis

(2013) Mitchell R. McGill et al.   PHARMACEUTICAL RESEARCH